Shivakumar L - Search Results

1

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

Burbee DG, Forgacs E, Zöchbauer-Müller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M, Minna JD. Burbee DG, et al. Among authors: shivakumar l. J Natl Cancer Inst. 2001 May 2;93(9):691-9. doi: 10.1093/jnci/93.9.691. J Natl Cancer Inst. 2001. PMID: 11333291 Free PMC article.

2

The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation.

Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. Shivakumar L, et al. Mol Cell Biol. 2002 Jun;22(12):4309-18. doi: 10.1128/MCB.22.12.4309-4318.2002. Mol Cell Biol. 2002. PMID: 12024041 Free PMC article.

3

The RASSF1A tumor suppressor restrains anaphase-promoting complex/cyclosome activity during the G1/S phase transition to promote cell cycle progression in human epithelial cells.

Whitehurst AW, Ram R, Shivakumar L, Gao B, Minna JD, White MA. Whitehurst AW, et al. Among authors: shivakumar l. Mol Cell Biol. 2008 May;28(10):3190-7. doi: 10.1128/MCB.02291-07. Epub 2008 Mar 17. Mol Cell Biol. 2008. PMID: 18347058 Free PMC article.

4

Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control.

English JM, Pearson G, Hockenberry T, Shivakumar L, White MA, Cobb MH. English JM, et al. Among authors: shivakumar l. J Biol Chem. 1999 Oct 29;274(44):31588-92. doi: 10.1074/jbc.274.44.31588. J Biol Chem. 1999. PMID: 10531364 Free article.

5

Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.

Holloway SE, Beck AW, Shivakumar L, Shih J, Fleming JB, Brekken RA. Holloway SE, et al. Among authors: shivakumar l. Ann Surg Oncol. 2006 Aug;13(8):1145-55. doi: 10.1245/ASO.2006.05.049. Epub 2006 Jun 21. Ann Surg Oncol. 2006. PMID: 16791450

6

Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.

Shivakumar L, Ansell S. Shivakumar L, et al. Clin Lymphoma Myeloma. 2006 Sep;7(2):106-8. doi: 10.3816/CLM.2006.n.046. Clin Lymphoma Myeloma. 2006. PMID: 17026820 Review.

7

Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma.

Shivakumar L, Armitage JO. Shivakumar L, et al. Clin Lymphoma Myeloma. 2006 May;6(6):455-7. doi: 10.3816/CLM.2006.n.025. Clin Lymphoma Myeloma. 2006. PMID: 16796775 Review.

8

42nd annual meeting of the American Society of Clinical Oncology June 2006, Atlanta, GA.

Schwab C, Shivakumar L. Schwab C, et al. Among authors: shivakumar l. Clin Lymphoma Myeloma. 2006 Jul;7(1):16-24. doi: 10.1016/s1557-9190(11)70303-1. Clin Lymphoma Myeloma. 2006. PMID: 16879765 No abstract available.

9

Meeting highlights 6th International Congress on monoclonal antibodies in cancer, August 2006, Washington, DC.

Shivakumar L, Tyagi P. Shivakumar L, et al. Clin Lymphoma Myeloma. 2006 Nov;7(3):179-81. doi: 10.1016/s1557-9190(11)70328-6. Clin Lymphoma Myeloma. 2006. PMID: 17229331 No abstract available.

10

Barriers to Clinical Trial Implementation Among Community Care Centers.

Ebrahimi H, Megally S, Plotkin E, Shivakumar L, Salgia NJ, Zengin ZB, Meza L, Chawla N, Castro DV, Dizman N, Bhagat R, Liv S, Li X, Rock A, Liu S, Tripathi A, Dorff T, Oyer RA, Boehmer L, Pal S, Chehrazi-Raffle A. Ebrahimi H, et al. Among authors: shivakumar l. JAMA Netw Open. 2024 Apr 1;7(4):e248739. doi: 10.1001/jamanetworkopen.2024.8739. JAMA Netw Open. 2024. PMID: 38683608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters